HU9202318D0 - Method for preparing medical preparatives containing didesoxi-purine nucleoside - Google Patents
Method for preparing medical preparatives containing didesoxi-purine nucleosideInfo
- Publication number
- HU9202318D0 HU9202318D0 HU9202318A HU9202318A HU9202318D0 HU 9202318 D0 HU9202318 D0 HU 9202318D0 HU 9202318 A HU9202318 A HU 9202318A HU 9202318 A HU9202318 A HU 9202318A HU 9202318 D0 HU9202318 D0 HU 9202318D0
- Authority
- HU
- Hungary
- Prior art keywords
- purine nucleoside
- didesoxi
- reduced mass
- buffering systems
- insoluble
- Prior art date
Links
- 239000002212 purine nucleoside Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- 230000003139 buffering effect Effects 0.000 abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- SEIGJEJVIMIXIU-UHFFFAOYSA-J aluminum;sodium;carbonate;dihydroxide Chemical compound [Na+].O[Al+]O.[O-]C([O-])=O SEIGJEJVIMIXIU-UHFFFAOYSA-J 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 239000007910 chewable tablet Substances 0.000 abstract 1
- 229940015828 dihydroxyaluminum sodium carbonate Drugs 0.000 abstract 1
- 239000007919 dispersible tablet Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003834 purine nucleoside derivatives Chemical class 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73354791A | 1991-07-22 | 1991-07-22 | |
| US88220492A | 1992-05-13 | 1992-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9202318D0 true HU9202318D0 (en) | 1992-10-28 |
Family
ID=27112590
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9202318A HU9202318D0 (en) | 1991-07-22 | 1992-07-15 | Method for preparing medical preparatives containing didesoxi-purine nucleoside |
| HU9202375A HU220612B1 (hu) | 1991-07-22 | 1992-07-21 | Eljárás didezoxi-purin nukleozidokat tartalmazó orális gyógyászati készítmények előállítására |
| HU95P/P00275P HU211285A9 (en) | 1991-07-22 | 1995-06-20 | Oral dosing formulations of dideoxy purine nucleosides |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9202375A HU220612B1 (hu) | 1991-07-22 | 1992-07-21 | Eljárás didezoxi-purin nukleozidokat tartalmazó orális gyógyászati készítmények előállítására |
| HU95P/P00275P HU211285A9 (en) | 1991-07-22 | 1995-06-20 | Oral dosing formulations of dideoxy purine nucleosides |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5880106A (enExample) |
| EP (1) | EP0524579B1 (enExample) |
| JP (1) | JP3038456B2 (enExample) |
| KR (1) | KR960011772B1 (enExample) |
| CN (1) | CN1042299C (enExample) |
| AT (1) | ATE163855T1 (enExample) |
| AU (1) | AU657337B2 (enExample) |
| CA (1) | CA2074215C (enExample) |
| DE (1) | DE69224684T2 (enExample) |
| DK (1) | DK0524579T3 (enExample) |
| ES (1) | ES2113389T3 (enExample) |
| FI (1) | FI105153B (enExample) |
| GR (1) | GR3026332T3 (enExample) |
| HU (3) | HU9202318D0 (enExample) |
| IE (1) | IE922365A1 (enExample) |
| IL (1) | IL102519A (enExample) |
| MX (1) | MX9204256A (enExample) |
| NO (1) | NO300198B1 (enExample) |
| NZ (1) | NZ243567A (enExample) |
| PL (1) | PL295329A1 (enExample) |
| RU (1) | RU2089193C1 (enExample) |
| TW (1) | TW211521B (enExample) |
| ZA (1) | ZA925484B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122207B2 (en) * | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
| UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
| CA2300892A1 (en) * | 1998-06-18 | 1999-12-23 | The George Washington University | Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| US6174873B1 (en) * | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
| EP1311240A1 (en) * | 2000-08-14 | 2003-05-21 | Fertin Pharma A/S | Method for preparation of chewing gum with customer acceptable taste |
| US6887926B1 (en) | 2001-11-16 | 2005-05-03 | Oatey Co. | Bonding compositions for chlorinated polymers and methods of using the same |
| CN100415211C (zh) * | 2003-07-03 | 2008-09-03 | 上海现代药物制剂工程研究中心 | 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法 |
| RU2276992C2 (ru) * | 2004-07-12 | 2006-05-27 | Государственное учреждение системы высшего и послевузовского профессионального образования "Сибирский государственный медицинский университет" (ГУ СВ ПО СибГМУ) | Фармацевтический состав, обладающий ноотропной активностью |
| US20080299227A1 (en) * | 2007-05-30 | 2008-12-04 | Sunhealth Therapies, Inc. | Method for removal of HIV from the gastrointestinal tract and bile of HIV-infected subjects and for the prevention of drug failure and prevention of development of AIDS in HIV-infected subjects |
| US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| BRPI0922508A8 (pt) | 2008-12-23 | 2016-01-19 | Pharmasset Inc | Análogos de nucleosídeo |
| EP2376515A1 (en) | 2008-12-23 | 2011-10-19 | Pharmasset, Inc. | Synthesis of purine nucleosides |
| NZ593648A (en) | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
| CN102858790A (zh) | 2010-03-31 | 2013-01-02 | 吉利德制药有限责任公司 | 核苷氨基磷酸酯 |
| WO2011123672A1 (en) | 2010-03-31 | 2011-10-06 | Pharmasset, Inc. | Purine nucleoside phosphoramidate |
| EP2428201A1 (en) | 2010-09-08 | 2012-03-14 | Merck Serono S.A. | Oral administration of nucleoside monophosphates |
| PT3042910T (pt) | 2010-11-30 | 2019-04-16 | Gilead Pharmasset Llc | 2'-espiro-nucleósidos para utilização na terapia da hepatite c |
| CN102949406B (zh) * | 2011-08-31 | 2014-03-12 | 天津药物研究院 | 一种复方艾夫他滨药物组合物及其制备方法和用途 |
| AR089857A1 (es) * | 2012-02-02 | 2014-09-24 | Glaxosmithkline Llc | Comprimido antiacido para refrescar el aliento |
| KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
| CN104069126A (zh) * | 2014-07-02 | 2014-10-01 | 浙江康乐药业股份有限公司 | 一种治疗胃酸过多的药物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260596A (en) * | 1979-08-13 | 1981-04-07 | Bristol-Myers Company | Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same |
| US4339428A (en) * | 1980-08-18 | 1982-07-13 | Bristol-Myers Company | Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component |
| CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
| JPS62501712A (ja) * | 1985-08-26 | 1987-07-09 | アメリカ合衆国 | ２′、３′―ジデオキシイノシン、２′，３′―ジデオキシグアノシンまたは２′，３′―ジデオキシアデノシンを含有する抗ｈｔｌｖ―３／ｌａｖ剤 |
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| CH674148A5 (enExample) * | 1986-06-24 | 1990-05-15 | Racz Istvan | |
| WO1988002629A1 (en) * | 1986-10-16 | 1988-04-21 | American Health Products Corporation | 2',3'-didesoxyadenosine composition |
| US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
| US5026687A (en) * | 1990-01-03 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds |
-
1992
- 1992-07-15 NZ NZ243567A patent/NZ243567A/en unknown
- 1992-07-15 HU HU9202318A patent/HU9202318D0/hu unknown
- 1992-07-16 TW TW081105639A patent/TW211521B/zh not_active IP Right Cessation
- 1992-07-16 JP JP4231248A patent/JP3038456B2/ja not_active Expired - Lifetime
- 1992-07-16 IL IL10251992A patent/IL102519A/en not_active IP Right Cessation
- 1992-07-16 NO NO922807A patent/NO300198B1/no not_active IP Right Cessation
- 1992-07-17 PL PL29532992A patent/PL295329A1/xx unknown
- 1992-07-20 EP EP92112371A patent/EP0524579B1/en not_active Expired - Lifetime
- 1992-07-20 DK DK92112371.7T patent/DK0524579T3/da active
- 1992-07-20 AT AT92112371T patent/ATE163855T1/de active
- 1992-07-20 FI FI923308A patent/FI105153B/fi not_active IP Right Cessation
- 1992-07-20 DE DE69224684T patent/DE69224684T2/de not_active Expired - Lifetime
- 1992-07-20 AU AU20396/92A patent/AU657337B2/en not_active Expired
- 1992-07-20 ES ES92112371T patent/ES2113389T3/es not_active Expired - Lifetime
- 1992-07-20 CA CA002074215A patent/CA2074215C/en not_active Expired - Fee Related
- 1992-07-21 HU HU9202375A patent/HU220612B1/hu unknown
- 1992-07-21 KR KR1019920012989A patent/KR960011772B1/ko not_active Expired - Lifetime
- 1992-07-21 IE IE236592A patent/IE922365A1/en not_active IP Right Cessation
- 1992-07-21 CN CN92108657A patent/CN1042299C/zh not_active Expired - Lifetime
- 1992-07-21 ZA ZA925484A patent/ZA925484B/xx unknown
- 1992-07-21 RU SU925052174A patent/RU2089193C1/ru active
- 1992-07-21 MX MX9204256A patent/MX9204256A/es unknown
-
1995
- 1995-06-20 HU HU95P/P00275P patent/HU211285A9/hu unknown
-
1997
- 1997-10-02 US US08/942,660 patent/US5880106A/en not_active Expired - Lifetime
-
1998
- 1998-03-12 GR GR970402511T patent/GR3026332T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9202318D0 (en) | Method for preparing medical preparatives containing didesoxi-purine nucleoside | |
| IT1211484B (it) | Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo | |
| HUT61989A (en) | Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient | |
| MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
| PT90466A (pt) | Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina | |
| CZ141995A3 (en) | Effervescent pharmaceutical preparation containing ibuprofen and process for preparing thereof | |
| CA2121345A1 (en) | Lipophilic Oligosaccharide Antibiotic Salt Compositions | |
| JPS56140924A (en) | Calcitonin pharmaceutical preparation | |
| GB2282758A (en) | Oral morphine-6-glucuronide compositions | |
| TH7600B (th) | สูตรผสมซึ่งให้ทางปากที่ดีขึ้นของไดดีออกซีพิวรีนนิวคลีโอไซด์ | |
| TH13488A (th) | สูตรผสมซึ่งให้ทางปากที่ดีขึ้นของไดดีออกซีพิวรีนนิวคลีโอไซด์ |